Cost-effectiveness acceptability curve for number of urinary tract infections prevented during 12 months (cranberry prophylaxis vs TMP-SMX prophylaxis).

<p>Abbreviations: TMP-SMX, trimethoprim-sulfametoxazole; UTI, Urinary Tract Infection.</p

Flow of participants through the trial.

<p>The lack of efficacy was determined by the patients. Abbreviations: TMP-SMX, trimethoprim-sulfametoxazole.</p

Cost-effectiveness plane for number of urinary tract infections prevented during 12 months (cranberry prophylaxis vs TMP-SMX prophylaxis).

<p>The black dot indicates the point estimate of the ICER (1.6 prevented UTIs less and €247 more costs in the cranberry group as compared to the TMP-SMX group) and the grey dots indicate the bootstrapped cost-effect pairs to reflect the uncertainty around the ICER. Abbreviations: ICER, Incremental Cost-Effectiveness Ratio; TMP-SMX, trimethoprim-sulfametoxazole; UTI, Urinary Tract Infection.</p

Cost-effectiveness plane.

<p>The cost-effectiveness plane shows for each strategy the expected proportion of correctly classified women (x-axis) and expected costs (y-axis). By drawing a line between strategies 13, 7, 3 and 4 (dominant strategies) the efficiency frontier is revealed.</p

Cost-effectiveness plane for the univariate sensitivity analysis.

<p>The cost-effectiveness plane shows the efficiency frontiers for the univariate sensitivity analyses in which the prevalence of urinary tract infection was varied by plus and minus 10% and 20%.</p

Expected proportion of correctly classified women, expected costs and incremental cost per correctly classified woman for all test strategies in the main analysis and the two univariate sensitivity analyses excluding strategies containing a dipslide and strategies containing a sediment.

<p>Expected proportion of correctly classified women, expected costs and incremental cost per correctly classified woman for all test strategies in the main analysis and the two univariate sensitivity analyses excluding strategies containing a dipslide and strategies containing a sediment.</p

Diagnostic strategies evaluated in the decision trees derived from empirical data on 196 women contacting their GP with painful and/or frequent micturition.

<p>Diagnostic strategies evaluated in the decision trees derived from empirical data on 196 women contacting their GP with painful and/or frequent micturition.</p

Cost-effectiveness plane for the differences in QALY scores at 6 months (in Euros).

<p>Cost-effectiveness plane for the differences in QALY scores at 6 months (in Euros).</p

Cost-effectiveness plane for the difference in quality of care sum score at 6 months (in Euros).

<p>Cost-effectiveness plane for the difference in quality of care sum score at 6 months (in Euros).</p

Differences in clinical outcomes at 6 months.

*<p>Lower scores indicate better quality of care.</p